Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109408963> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2109408963 endingPage "193" @default.
- W2109408963 startingPage "186" @default.
- W2109408963 abstract "Introduction: Nowhere in the world is there a clear guide for what we must do for patients with gastric neuroendocrine tumors (gastric NETs). Although mucosectomy is often advised for lesions of less than 1cm in which there are no metastases, some groups advocate surgical management. In addition, it is not clear how treated patients should be followed up. The aim of this study is to describe our experience in the endoscopic management of these patients. Patients and methods: This is a retrospective and descriptive study conducted over a 4 year period at two institutions. Different variables were recorded in a data collection instrument specifically designed for this investigation. Data collected included socio-demographic characteristics, clinical presentation of symptoms, endoscopic findings, tests ordered, whether surgical or endoscopic treatment was chosen, descriptions of endoscopic technique used for resection, the number and sizes of lesions, patients' clinical development and patient outcomes. Results: Altogether the study included 29 gastric NET patients who had a total of 43 lesions. 28 patients had were NET type I tumors while one case was type III. The average age at diagnosis was 55 ± 10 years; 64% were women. 23 patients had tumors in the gastric corpus, 4 in the gastric fundus and 2 in the antrum. 14 patients (17.2%) had pernicious anemia. All 28 patients with type I NETs were treated endoscopically. Endoscopic methods included 17 (60.7%) mucosectomies with loops, 4 (14.2%) mucosal resections with caps, and 7 (25%).mucosectomies with bands. Surveillance of patients from diagnosis to the date of the study averaged 32.5 months (6 - 47 months). The patient who had been diagnosed with NET III died. The survival rate for patients with type I gastric NETs is 100%. Conclusion: Patients with Type I NETs have excellent prognoses. In this study their survival rate was 100% during the follow-up period. Endoscopic treatment is safe and effective for these patients when the mucosectomy techniques described in the literature are used." @default.
- W2109408963 created "2016-06-24" @default.
- W2109408963 creator A5011698447 @default.
- W2109408963 creator A5063812038 @default.
- W2109408963 creator A5073009494 @default.
- W2109408963 date "2011-09-01" @default.
- W2109408963 modified "2023-09-24" @default.
- W2109408963 title "Manejo endoscópico de los tumores neuroendocrinos gástricos" @default.
- W2109408963 cites W1577533165 @default.
- W2109408963 cites W1594108527 @default.
- W2109408963 cites W1826781214 @default.
- W2109408963 cites W1970458699 @default.
- W2109408963 cites W1970620056 @default.
- W2109408963 cites W1990509102 @default.
- W2109408963 cites W1995037065 @default.
- W2109408963 cites W2000153070 @default.
- W2109408963 cites W2004254863 @default.
- W2109408963 cites W2028133886 @default.
- W2109408963 cites W2033006867 @default.
- W2109408963 cites W2037727477 @default.
- W2109408963 cites W2041644816 @default.
- W2109408963 cites W2049173484 @default.
- W2109408963 cites W2075300012 @default.
- W2109408963 cites W2093975374 @default.
- W2109408963 cites W2106805342 @default.
- W2109408963 cites W2108800127 @default.
- W2109408963 cites W2132350514 @default.
- W2109408963 cites W2138900427 @default.
- W2109408963 cites W2143273602 @default.
- W2109408963 cites W2152527089 @default.
- W2109408963 cites W2163641153 @default.
- W2109408963 cites W2282751749 @default.
- W2109408963 cites W2416463450 @default.
- W2109408963 cites W89297768 @default.
- W2109408963 cites W1508978294 @default.
- W2109408963 hasPublicationYear "2011" @default.
- W2109408963 type Work @default.
- W2109408963 sameAs 2109408963 @default.
- W2109408963 citedByCount "0" @default.
- W2109408963 crossrefType "journal-article" @default.
- W2109408963 hasAuthorship W2109408963A5011698447 @default.
- W2109408963 hasAuthorship W2109408963A5063812038 @default.
- W2109408963 hasAuthorship W2109408963A5073009494 @default.
- W2109408963 hasConcept C126322002 @default.
- W2109408963 hasConcept C141071460 @default.
- W2109408963 hasConcept C167135981 @default.
- W2109408963 hasConcept C2778248108 @default.
- W2109408963 hasConcept C2778451229 @default.
- W2109408963 hasConcept C2778866283 @default.
- W2109408963 hasConcept C61434518 @default.
- W2109408963 hasConcept C71924100 @default.
- W2109408963 hasConceptScore W2109408963C126322002 @default.
- W2109408963 hasConceptScore W2109408963C141071460 @default.
- W2109408963 hasConceptScore W2109408963C167135981 @default.
- W2109408963 hasConceptScore W2109408963C2778248108 @default.
- W2109408963 hasConceptScore W2109408963C2778451229 @default.
- W2109408963 hasConceptScore W2109408963C2778866283 @default.
- W2109408963 hasConceptScore W2109408963C61434518 @default.
- W2109408963 hasConceptScore W2109408963C71924100 @default.
- W2109408963 hasIssue "3" @default.
- W2109408963 hasLocation W21094089631 @default.
- W2109408963 hasOpenAccess W2109408963 @default.
- W2109408963 hasPrimaryLocation W21094089631 @default.
- W2109408963 hasVolume "26" @default.
- W2109408963 isParatext "false" @default.
- W2109408963 isRetracted "false" @default.
- W2109408963 magId "2109408963" @default.
- W2109408963 workType "article" @default.